162 related articles for article (PubMed ID: 1526698)
1. Methods for clinical assessment of expectorants: a critical review.
Lurie A; Mestiri M; Huchon G; Marsac J; Lockhart A; Strauch G; Bergogne-Berezin E; Bignon J; Carbon C; Chwalow J
Int J Clin Pharmacol Res; 1992; 12(1):47-52. PubMed ID: 1526698
[TBL] [Abstract][Full Text] [Related]
2. Clinical evaluation of new therapies for treatment of mucus hypersecretion in respiratory diseases.
Disse B
Novartis Found Symp; 2002; 248():254-72; discussion 272-6, 277-82. PubMed ID: 12568499
[TBL] [Abstract][Full Text] [Related]
3. [Novel approach to respiratory pharmacology--pharmacological basis of cough, sputum and airway clearance].
Miyata T
Yakugaku Zasshi; 2003 Dec; 123(12):987-1006. PubMed ID: 14689863
[TBL] [Abstract][Full Text] [Related]
4. The pharmacologic approach to airway clearance: mucoactive agents.
Rubin BK
Paediatr Respir Rev; 2006; 7 Suppl 1():S215-9. PubMed ID: 16798570
[TBL] [Abstract][Full Text] [Related]
5. Review on sobrerol as a muco-modifying drug: experimental data and clinical findings in hypersecretory bronchopulmonary diseases.
Braga PC; Allegra L; Bossi R; Scuri R; Castiglioni CL; Romandini S
Int J Clin Pharmacol Res; 1987; 7(5):381-400. PubMed ID: 3312046
[TBL] [Abstract][Full Text] [Related]
6. [Mucociliary clearance function and medicamentous modification].
Konrad F
Anasthesiol Intensivmed Notfallmed Schmerzther; 1996 Sep; 31(7):404-8. PubMed ID: 8991466
[TBL] [Abstract][Full Text] [Related]
7. The pharmacologic approach to airway clearance: mucoactive agents.
Rubin BK
Respir Care; 2002 Jul; 47(7):818-22. PubMed ID: 12088552
[TBL] [Abstract][Full Text] [Related]
8. Mucoactive agents for airway mucus hypersecretory diseases.
Rogers DF
Respir Care; 2007 Sep; 52(9):1176-93; discussion 1193-7. PubMed ID: 17716385
[TBL] [Abstract][Full Text] [Related]
9. [Expectorants: an expensive, mostly ineffective therapy of chronic cough].
Medici TC; Züllig A; Schmid A
Schweiz Rundsch Med Prax; 1988 Sep; 77(39):1048-54. PubMed ID: 3051267
[No Abstract] [Full Text] [Related]
10. [Effectiveness and tolerance of a new molecule with secreto-dynamic activity: nesosteine].
Gatto PG; Gramolini C; Valenti S
Clin Ter; 1989 Jan; 128(2):87-97. PubMed ID: 2523778
[TBL] [Abstract][Full Text] [Related]
11. Pharmacotherapy of impaired mucociliary clearance in non-CF pediatric lung disease. A review of the literature.
Boogaard R; de Jongste JC; Merkus PJ
Pediatr Pulmonol; 2007 Nov; 42(11):989-1001. PubMed ID: 17902149
[TBL] [Abstract][Full Text] [Related]
12. Effect of a single 1200 Mg dose of Mucinex® on mucociliary and cough clearance during an acute respiratory tract infection.
Bennett WD; Kala A; Duckworth H; Zeman KL; Wu J; Henderson A; Yopp M; Rubin BK
Respir Med; 2015 Nov; 109(11):1476-83. PubMed ID: 26462765
[TBL] [Abstract][Full Text] [Related]
13. [Effectiveness of pharmacologic and non-pharmacologic methods of restoring bronchial patency].
Lunichkina IV; Solopov VN
Klin Med (Mosk); 1989 Jun; 67(6):109-11. PubMed ID: 2779144
[TBL] [Abstract][Full Text] [Related]
14. [Ambroxol].
Akkoca Yildiz O
Tuberk Toraks; 2006; 54 Suppl 1():3-14. PubMed ID: 17089236
[No Abstract] [Full Text] [Related]
15. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
16. [Action mechanisms of cough suppressants and their clinical application].
Płusa T
Pol Merkur Lekarski; 2014 Jan; 36(211):48-53. PubMed ID: 24645580
[TBL] [Abstract][Full Text] [Related]
17. Mucolytic agents and mucociliary activity.
Gunnarsson M; Hybbinette JC; Mercke U
Rhinology; 1984 Dec; 22(4):223-31. PubMed ID: 6151739
[TBL] [Abstract][Full Text] [Related]
18. [Bronchial mucus modifiers, antioxidants and antiproteases].
Polu JM; Chabot F; Wallaert B
Rev Mal Respir; 1993; 10(2):87-100. PubMed ID: 8502804
[No Abstract] [Full Text] [Related]
19. Inhaled mannitol for the treatment of mucociliary dysfunction in patients with bronchiectasis: effect on lung function, health status and sputum.
Daviskas E; Anderson SD; Gomes K; Briffa P; Cochrane B; Chan HK; Young IH; Rubin BK
Respirology; 2005 Jan; 10(1):46-56. PubMed ID: 15691238
[TBL] [Abstract][Full Text] [Related]
20. Rheological profile of nesosteine: a new mucoactive agent.
Braga PC; Beghi G; Castelli C; Grasselli G; Ornaghi A; Rampoldi C; Zheng Y; Allegra L
Int J Clin Pharmacol Res; 1989; 9(1):77-83. PubMed ID: 2707929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
